News
March 14, 2018

CJEU rules that a Concerned Member State cannot determine the regulatory data protection period of a reference medicinal product

BioSlice Blog
By Libby Amos Jacqueline Mulryne
Find more content tagged:

People

Libby Amos
Libby Amos
Associate
London
+44 (0)20 7786 6193
Email
VCard
Jacqueline Mulryne
Jacqueline Mulryne
Partner
London
+44 (0)20 7786 6123
Email
VCard

Related Content

July 31, 2020
Update: Regulation for COVID-19 clinical trials conducted with medicinal products containing or consisting of GMOs has now been adopted
BioSlice Blog
July 24, 2020
Strict sufficiency
Intellectual Property Magazine
July 2020
An Overview of EU Rules on Consumer Advertising of Over-the-Counter Products in the Life Sciences Sector
International Comparative Legal Guide to: Pharmaceutical Advertising Laws and Regulations 2020, 17th Edition, (London: Global Legal Group, Ltd.)
Subscribe
Subscribe Link

Email Disclaimer

Reject Accept